Ablation Equipments - Medical Devices Pipeline Assessment, 2018

  • ID: 4601485
  • Report
  • 143 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AngioDynamics Inc
  • CPSI Biotech
  • Deneb Medical SL
  • Harmonic Medical Inc
  • Innoblative Designs, Inc.
  • Medtronic plc
  • MORE
Ablation Equipments - Medical Devices Pipeline Assessment, 2018

Summary

The author's Medical Devices sector report, “Ablation Equipments - Medical Devices Pipeline Assessment, 2018" provides an overview of Ablation Equipments currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ablation Equipments pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Ablation Equipments under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Ablation Equipments and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Ablation Equipments under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AngioDynamics Inc
  • CPSI Biotech
  • Deneb Medical SL
  • Harmonic Medical Inc
  • Innoblative Designs, Inc.
  • Medtronic plc
  • MORE
1 Table of Contents

2 Introduction
2.1 Ablation Equipments Overview

3 Products under Development
3.1 Ablation Equipments - Pipeline Products by Stage of Development
3.2 Ablation Equipments - Pipeline Products by Territory
3.3 Ablation Equipments - Pipeline Products by Regulatory Path
3.4 Ablation Equipments - Pipeline Products by Estimated Approval Date
3.5 Ablation Equipments - Ongoing Clinical Trials

4 Ablation Equipments - Pipeline Products under Development by Companies
4.1 Ablation Equipments Companies - Pipeline Products by Stage of Development
4.2 Ablation Equipments - Pipeline Products by Stage of Development

5 Ablation Equipments Companies and Product Overview
5.1 AngioDynamics Inc Company Overview
5.1.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Avenda Health Inc Company Overview
5.2.1 Avenda Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 CPSI Biotech Company Overview
5.3.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
5.4 Creo Medical Ltd. Company Overview
5.4.1 Creo Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.5 Deneb Medical SL Company Overview
5.5.1 Deneb Medical SL Pipeline Products & Ongoing Clinical Trials Overview
5.6 Fractyl Laboratories Inc Company Overview
5.6.1 Fractyl Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Harmonic Medical Inc Company Overview
5.7.1 Harmonic Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 HistoSonics Inc Company Overview
5.8.1 HistoSonics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.9 Hospital for Special Surgery Company Overview
5.9.1 Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview
5.10 Imricor Medical Systems Inc Company Overview
5.10.1 Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Innoblative Designs, Inc. Company Overview
5.11.1 Innoblative Designs, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.12 Integra LifeSciences Holdings Corp Company Overview
5.12.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview
5.13 Intratherm LLC (Inactive) Company Overview
5.13.1 Intratherm LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.14 Massachusetts Institute of Technology Company Overview
5.14.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
5.15 Medtronic plc Company Overview
5.15.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Memorial Sloan Kettering Cancer Center Company Overview
5.16.1 Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
5.17 Mirabilis Medical Inc Company Overview
5.17.1 Mirabilis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Pulse Biosciences Inc Company Overview
5.18.1 Pulse Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Southern Illinois University Carbondale Company Overview
5.19.1 Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview
5.20 Thermedical Inc Company Overview
5.20.1 Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 TransEnterix Inc Company Overview
5.21.1 TransEnterix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.22 University of California San Francisco Company Overview
5.22.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
5.23 University of Texas at Austin Company Overview
5.23.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview
5.24 University of Wisconsin-Stout Company Overview
5.24.1 University of Wisconsin-Stout Pipeline Products & Ongoing Clinical Trials Overview

6 Ablation Equipments- Recent Developments
6.1 Jul 11, 2018: AngioDynamics Reports Fiscal 2018 Fourth Quarter and Full-Year Financial Results
6.2 Jul 10, 2018: Stryker announces organizational changes
6.3 Jul 05, 2018: SonaCare reports long-term results of HIFU therapy for prostate cancer
6.4 Jun 23, 2018: Fractyl Announces Presentation of Key Scientific Research at ADA 2018 Indicating That Modern Diets Durably Alter Duodenal Lining, Highlighting the Intestine's Role in Type 2 Diabetes and NASH
6.5 Jun 14, 2018: HSS Hip and Knee Surgeon Bradford Waddell, MD, Named Chair of Young Arthroplasty Group
6.6 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value

7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Ablation Equipments - Pipeline Products by Stage of Development
Table 2: Ablation Equipments - Pipeline Products by Territory
Table 3: Ablation Equipments - Pipeline Products by Regulatory Path
Table 4: Ablation Equipments - Pipeline Products by Estimated Approval Date
Table 5: Ablation Equipments - Ongoing Clinical Trials
Table 6: Ablation Equipments Companies - Pipeline Products by Stage of Development
Table 7: Ablation Equipments - Pipeline Products by Stage of Development
Table 8: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: NanoKnife 3.0 - Product Status
Table 10: NanoKnife 3.0 - Product Description
Table 11: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Product Status
Table 12: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Product Description
Table 13: NanoKnife System - Pancreatic Cancer - Product Status
Table 14: NanoKnife System - Pancreatic Cancer - Product Description
Table 15: NanoKnife System - Prostate Cancer - Product Status
Table 16: NanoKnife System - Prostate Cancer - Product Description
Table 17: AngioDynamics Inc - Ongoing Clinical Trials Overview
Table 18: NanoKnife System - Prostate Cancer - Efficacy and Safety Assessment of Nanoknife (AngyoDynamics, USA) for Irreversible Electroporation (IRE) of Localized Prostate Cancer
Table 19: NanoKnife System - Prostate Cancer - Focal Irreversible Electroporation as Salvage Treatment in Radio-recurrent Prostate Cancer: A Prospective Multicenter Pilot Study
Table 20: NanoKnife System - Prostate Cancer - Irreversible Electroporation (IRE) for Unresectable Prostatic Neoplasms: Phase I and Phase II Clinical Trial
Table 21: NanoKnife System - Prostate Cancer - Multi-center Randomized Clinical Two Arm Intervention Study Evaluating Irreversible Electroporation for the Ablation of Localized Prostate Cancer
Table 22: NanoKnife System - Prostate Cancer - Registry of Irreversible Electroporation for the Ablation of Prostate Cancer with Use of Nanoknife Device; A Multi-center, International Registry to Evaluate the Treatment of Prostate Cancer in Terms of Recurrence, Functional Outcomes and Safety
Table 23: NanoKnife System - Pancreatic Cancer - A Clinical Research about Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer
Table 24: NanoKnife System - Pancreatic Cancer - A Pilot Study of Irreversible Electroporation for the Treatment of Upfront Resectable Pancreatic Cancer in the Head of the Pancreas
Table 25: NanoKnife System - Pancreatic Cancer - Assessing Optimal Treatment Settings for the Ablation of Locally Advanced Pancreatic Cancer with CT-guided Percutaneous Irreversible Electroporation (ANTILOPE): A Randomized Feasibility Study
Table 26: NanoKnife System - Pancreatic Cancer - Crossatlantic Randomized Controlled Trial Comparing Outcome in Survival after Systemic Plus Focal Therapy for Inoperable Pancreatic Carcinoma: Radiotherapy Versus Irreversible Electroporation: CROSSFIRE Trial
Table 27: NanoKnife System - Pancreatic Cancer - Evaluation of the Short and Intermediate Term Outcomes of Ablation of Locally Advanced Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System - A Prospective Study
Table 28: NanoKnife System - Pancreatic Cancer - Impact of Irreversible Electroporation on Quality of Life for Patients with Locally Advanced Pancreatic Cancer
Table 29: NanoKnife System - Pancreatic Cancer - Interest of Irreversible Electroporation in the Treatment of Pancreatic Adenocarcinoma
Table 30: NanoKnife System - Pancreatic Cancer - IRE: Anti-tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer
Table 31: NanoKnife System - Pancreatic Cancer - Irreversible Electroporation for Locally Advanced Pancreatic Ductal Adenocarcinoma (LEAP TRIAL): A Phase I/II Prospective Trial
Table 32: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - A Prospective Clinical Trial Using Irreversible Electroporation (IRE) for the Treatment of Unresectable Hepatic Carcinoma Close to the Gallbladder
Table 33: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - A Prospective Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers
Table 34: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Colorectal Metastatic Liver Disease: Efficacy of Irreversible Electroporation (IRE) - A Phase II Clinical Trial: COLDFIRE-2 Study
Table 35: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer
Table 36: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Comparison Percutaneous Cryosurgery and Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome
Table 37: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Hepatic Carcinoma in Poor Liver Function: Safety and Efficacy of Irreversible Electroporation (IRE)
Table 38: NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Irreversible Electroporation (IRE) for Unresectable Portal Venous Tumor Emboli: Phase I and Phase II Clinical Trial
Table 39: NanoKnife 3.0 - The Safety and Feasibility of Irreversible Electroporation for the Ablation of Small Renal Masses
Table 40: Avenda Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Fiber - Optic Laser - Product Status
Table 42: Fiber - Optic Laser - Product Description
Table 43: CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Pressurized Sub-Cooled Nitrogen System - Product Status
Table 45: Pressurized Sub-Cooled Nitrogen System - Product Description
Table 46: Super-Critical Nitrogen (SCN) Cryoablation Platform - Product Status
Table 47: Super-Critical Nitrogen (SCN) Cryoablation Platform - Product Description
Table 48: Creo Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 49: Flexible Ablation System - Product Status
Table 50: Flexible Ablation System - Product Description
Table 51: Deneb Medical SL Pipeline Products & Ongoing Clinical Trials Overview
Table 52: BoneCut Collaborative Robot - Product Status
Table 53: BoneCut Collaborative Robot - Product Description
Table 54: Fractyl Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 55: Revita DMR System - Product Status
Table 56: Revita DMR System - Product Description
Table 57: Fractyl Laboratories Inc - Ongoing Clinical Trials Overview
Table 58: Revita DMR System - Evaluation of Duodenal Mucosal Resurfacing (DMR) for the Treatment of Non Alcoholic Steatohepatitis (NASH), a Proof of Concept Study
Table 59: Revita DMR System - Evaluation of Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes
Table 60: Revita DMR System - Evaluation of the Effect of Duodenal Mucosal Resurfacing (DMR) Using the Revita System in the Treatment of Type 2 Diabetes (T2D)
Table 61: Revita DMR System - Multicenter Clinical Trial of Revita DMR Procedure in Patients with Diabetes
Table 62: Harmonic Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Symphony MRI guided High Intensity Focused Ultrasound - Leiomyomas - Product Status
Table 64: Symphony MRI guided High Intensity Focused Ultrasound - Leiomyomas - Product Description
Table 65: Harmonic Medical Inc - Ongoing Clinical Trials Overview
Table 66: Symphony MRI guided High Intensity Focused Ultrasound - Leiomyomas - MRI-guided High Intensity Focused Ultrasound Ablation of Leiomyomas. Single Arm, Feasibility Study Using the Symphony - MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas.
Table 67: HistoSonics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Vortx RX - Product Status
Table 69: Vortx RX - Product Description
Table 70: Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Radiofrequency Ablation Device - Product Status
Table 72: Radiofrequency Ablation Device - Product Description
Table 73: Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 74: Vision MR Ablation Catheter - Product Status
Table 75: Vision MR Ablation Catheter - Product Description
Table 76: Imricor Medical Systems Inc - Ongoing Clinical Trials Overview

List of Figures
Figure 1: Ablation Equipments - Pipeline Products by Stage of Development
Figure 2: Ablation Equipments - Pipeline Products by Territory
Figure 3: Ablation Equipments - Pipeline Products by Regulatory Path
Figure 4: Ablation Equipments - Pipeline Products by Estimated Approval Date
Figure 5: Ablation Equipments - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AngioDynamics Inc
  • Avenda Health Inc
  • CPSI Biotech
  • Creo Medical Ltd.
  • Deneb Medical SL
  • Fractyl Laboratories Inc
  • Harmonic Medical Inc
  • HistoSonics Inc
  • Hospital for Special Surgery
  • Imricor Medical Systems Inc
  • Innoblative Designs, Inc.
  • Integra LifeSciences Holdings Corp
  • Intratherm LLC
  • Massachusetts Institute of Technology
  • Medtronic plc
  • Memorial Sloan Kettering Cancer Center
  • Mirabilis Medical Inc
  • Pulse Biosciences Inc
  • Southern Illinois University Carbondale
  • Thermedical Inc
  • TransEnterix Inc
  • University of California San Francisco
  • University of Texas at Austin
  • University of Wisconsin-Stout
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll